ArticleThe Journal of investigative dermatology2014

Intratumoral CD4+ T lymphodepletion sensitizes poorly immunogenic melanomas to immunotherapy with an OX40 agonist.

Susumu Fujiwara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.